Equity Incentive Plans and Stock-Based Compensation (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Black-Scholes Option Pricing Model to Estimate Stock-based Compensation Expense for Stock Option Awards |
The Company used Black-Scholes option pricing model to estimate stock-based compensation expense for stock option awards with the following assumptions: | | | | | | | | | | | | | | Three months ended March 31, | | | 2024 | | 2023 | | Expected volatility | 85.28% - 86.42% | | 80.97% - 81.41% | | Risk-free interest rate | 4.04% - 4.28% | | 3.42% - 4.18% | | Expected dividend | — | | — | | Expected term (in years) | 5.99 - 6.06 | | 5.77 - 6.08 | | Underlying common stock fair value | $15.19 - $17.44 | | $21.94 - $34.65 |
|
| Schedule of Option Activity Under the 2015 Plan and 2020 Plan |
A summary of option activity under the 2015 Plan and the 2020 Plan is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options | | Weighted- Average Exercise Price per Share | | Weighted- Average Remaining Contractual Term (in Years) | | Aggregate Intrinsic Value | | Outstanding as of December 31, 2023 | 6,953,487 | | | $ | 17.95 | | | 7.70 | | $ | 32,646 | | | Granted | 1,338,465 | | | $ | 17.29 | | | | | | | Exercised | (118,573) | | | $ | 8.01 | | | | | | | Forfeited | (513,519) | | | $ | 16.87 | | | | | | | Outstanding as of March 31, 2024 | 7,659,860 | | | $ | 18.06 | | | 7.83 | | $ | 18,505 | | | Exercisable as of March 31, 2024 | 7,659,860 | | | $ | 18.06 | | | 7.83 | | $ | 18,505 | | | Vested and expected to vest as of March 31, 2024 | 3,651,242 | | | $ | 15.84 | | | 6.70 | | $ | 15,456 | |
|
| Schedule of Restricted Stock Activity |
The following table sets forth the outstanding RSUs and related activity for the three months ended March 31, 2024 | | | | | | | | | | | | | Restricted Stock Units | | Weighted Average Grant Date Fair Value | | Unvested and outstanding as of December 31, 2023 | 874,748 | | | $ | 29.85 | | | Granted | 594,336 | | | $ | 17.44 | | | Released | (210,085) | | | $ | 34.65 | | | Forfeited | (57,275) | | | $ | 27.88 | | | Unvested and outstanding as of March 31, 2024 | 1,201,724 | | | $ | 22.97 | |
|
| Schedule of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions |
The fair value of the TSR PSUs were derived from a Monte Carlo simulation model that used the following key assumptions: | | | | | | | | | | Valuation date share price | | $ | 17.57 | | | Award term (years) | | 1.92 | | Volatility | | 70.62 | % | | Correlation coefficient | | 0.3508 | | Average peer group volatility | | 79.69 | % | | Average peer group correlation coefficient | | 0.4397 | Risk-free interest rate | | 2.84 | % |
|
| Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity |
The following table sets forth the outstanding PSUs associated with TSR goal and related activity during the three months ended March 31, 2024: | | | | | | | | | | | | | Performance Stock Units | | Weighted Average Grant Date Fair Value | | Unvested balance at December 31, 2023 | 328,752 | | | $29.15 | | Forfeited | (46,407) | | | $29.15 | | Unvested balance at March 31, 2024 | 282,345 | | | $29.15 |
|
| Schedule of Black-Scholes Option Pricing Model to Estimate Stock-based Compensation Expense for 2020 Employee Stock Purchase Plan |
The Company used Black-Scholes option pricing model to estimate stock-based compensation expense for the 2020 ESPP with the following assumptions: | | | | | | | | | | | | | | | | | | Three months ended March 31, | | | | 2024 | | 2023 | | Risk-free interest rate | | 5.27% | | 5.20% | | Expected term of options (in years) | | 0.50 | | 0.50 | | Expected stock price volatility | | 63.92% | | 69.15% | | Expected dividends | | — | | — |
|
| Schedule of Classification of Stock-based Compensation Expense |
The following table presents the components and classification of stock-based compensation expense for the Company’s stock-based awards for the three months ended March 31, 2024 and 2023 (in thousands): | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | 2024 | | 2023 | | Stock options and ESPP | | $ | 6,358 | | | $ | 4,803 | | | Restricted stock units | | 3,246 | | | 2,606 | | | Performance-based restricted stock units | | 62 | | | 4,514 | | | Total stock-based compensation expense | | $ | 9,666 | | | $ | 11,923 | | | Research and development expenses | | $ | 3,070 | | | $ | 4,848 | | | General and administrative expenses | | $ | 6,596 | | | $ | 7,075 | |
|